Shattuck Labs, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CCCC
|
C4 Therapeutics, Inc. | $5.40 | $320.64 M | -1.97 | 145 | $20.76 M |
 CSBR
|
Champions Oncology, Inc. | $4.79 | $62.53 M | -6.39 | 210 | $50.16 M |
 ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
 FHTX
|
Foghorn Therapeutics Inc. | $7.87 | $332.53 M | -2.73 | 116 | $34.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.10 | $243.38 M | -1.59 | 129 | $0 |
 IPSC
|
Century Therapeutics, Inc. | $1.56 | $244.54 M | -1.32 | 152 | $2.24 M |
 KYMR
|
Kymera Therapeutics, Inc. | $42.73 | $2.02 B | -13.13 | 181 | $78.59 M |
 NRIX
|
Nurix Therapeutics, Inc. | $22.17 | $930.10 M | -5.89 | 284 | $76.99 M |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.51 | $85.40 M | -1.26 | 63 | $0 |
 PRDS
|
Pardes Biosciences, Inc. | $2.18 | $135.19 M | -1.7 | 57 | $0 |
 PRLD
|
Prelude Therapeutics Incorporated | $2.00 | $205.99 M | -2.02 | 128 | $0 |
 STOK
|
Stoke Therapeutics, Inc. | $11.72 | $774.50 M | -6.14 | 110 | $8.78 M |